You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proleukin

Showing 1 - 25 of 218
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

Completed
  • Stage III Malignant Melanoma of Skin AJCC V6
  • Stage IV Malignant Melanoma of Skin
  • TAPCells vaccine
  • Santiago, RM, Chile
    Faculty of Medicine, University of Chile
Nov 21, 2023

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Metastatic Melanoma Trial in Louisville (Proleukin and Dacarbazine)

Active, not recruiting
  • Metastatic Melanoma
  • Proleukin and Dacarbazine
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Proleukin 1.3 MG Injection
  • (no location specified)
Apr 6, 2023

Metastatic Melanoma Trial in Tampa (procedure, drug, other)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Surgery
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Alzheimer Trial in Paris (Proleukin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • Proleukin
  • Placebo
  • Paris, France
    GHU Saint Anne
Jul 18, 2022

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

Completed
Has Results
  • Metastatic Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Encephalitis Trial (Proleukin)

Completed
  • Encephalitis
  • Proleukin
  • (no location specified)
Sep 23, 2021

Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • HD IL2
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jun 20, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

Completed
  • Covid19
  • Ixekizumab
  • +3 more
  • Ribeirão Preto, SP, Brazil
  • +1 more
Jul 26, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

HIV Trial run by the NIAID (Interleukin-2)

Completed
  • HIV Infections
  • Bethesda, Maryland
    NIH Intramural Research Program ACTG CRS
Oct 28, 2021

Renal Cell Carcinoma Trial in Portland (High Dose IL-2, SBRT)

Active, not recruiting
  • Renal Cell Carcinoma
  • High Dose IL-2
  • SBRT
  • Portland, Oregon
    Portland Providence Medical Center
Jan 31, 2022

Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)

Completed
  • Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022